427 related articles for article (PubMed ID: 18991629)
1. A review of coumarin derivatives in pharmacotherapy of breast cancer.
Musa MA; Cooperwood JS; Khan MO
Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
[TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S
Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review.
Jameera Begam A; Jubie S; Nanjan MJ
Bioorg Chem; 2017 Apr; 71():257-274. PubMed ID: 28274582
[TBL] [Abstract][Full Text] [Related]
4. A Review on Pharmacological Properties of Coumarins.
Srikrishna D; Godugu C; Dubey PK
Mini Rev Med Chem; 2018; 18(2):113-141. PubMed ID: 27488585
[TBL] [Abstract][Full Text] [Related]
5. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
Song F; Huo X; Guo Z
Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.
Chen S; Cho M; Karlsberg K; Zhou D; Yuan YC
J Biol Chem; 2004 Nov; 279(46):48071-8. PubMed ID: 15358790
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
8. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
Bhatia R; Rawal RK
Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
[TBL] [Abstract][Full Text] [Related]
9. Coumarin-Fatty Acid Conjugates as Potential ERα/AKT-1 Antagonists for ER Positive Breast Cancer.
Selvaraj J; John JBA; Joghee NM; Antony J; Wadhwani A; Natarajan J
Anticancer Agents Med Chem; 2020; 20(4):437-449. PubMed ID: 31746305
[TBL] [Abstract][Full Text] [Related]
10. Medicinal applications of coumarins bearing azetidinone and thiazolidinone moieties.
Patil SA; Patil SA; Fariyike T; Marichev KO; Heras Martinez HM; Bugarin A
Future Med Chem; 2021 Nov; 13(21):1907-1934. PubMed ID: 34468216
[TBL] [Abstract][Full Text] [Related]
11. A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents.
Mujeeb S; Singh K; Yogi B; Ansari V; Sinha S
Mini Rev Med Chem; 2022; 22(7):1064-1080. PubMed ID: 34579635
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
[TBL] [Abstract][Full Text] [Related]
13. Anticancer mechanism of coumarin-based derivatives.
Yadav AK; Maharjan Shrestha R; Yadav PN
Eur J Med Chem; 2024 Mar; 267():116179. PubMed ID: 38340509
[TBL] [Abstract][Full Text] [Related]
14. Translational role of natural coumarins and their derivatives as anticancer agents.
Menezes JC; Diederich M
Future Med Chem; 2019 May; 11(9):1057-1082. PubMed ID: 31140865
[TBL] [Abstract][Full Text] [Related]
15. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
Emami S; Dadashpour S
Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
[TBL] [Abstract][Full Text] [Related]
16. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
17. A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer.
Venkata Sairam K; Gurupadayya BM; Chandan RS; Nagesha DK; Vishwanathan B
Curr Drug Deliv; 2016; 13(2):186-201. PubMed ID: 26135671
[TBL] [Abstract][Full Text] [Related]
18. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
Keri RS; Budagumpi S; Balappa Somappa S
J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
[TBL] [Abstract][Full Text] [Related]
19. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
